Skip to content

The Optimization of Procedural Pain Control in Intensive Care Unit (ICU) Patients

Randomised Clinical Trial of the Optimization of Procedural Pain Control in ICU Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00558090
Acronym
OPCIC
Enrollment
150
Registered
2007-11-14
Start date
2008-02-29
Completion date
2010-02-28
Last updated
2010-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

pain, Intensive Care Unit, morphine, pKpD, numerical rating scale, critically ill patients

Brief summary

The purpose of this study is to determine the influence of morphine 2,5 mg or morphine 7,5 mg iv during a painful and unavoidable intervention in critically ill patients.

Detailed description

In 2006, in the Intensive Care Unit (ICU) of the St. Antonius Hospital an analgesia improvement program has been implemented. This program consisted of training of ICU nurses and intensivists using a hospital based standardized pain protocol, and systematic pain measurements in rest, rated by the patient himself whenever possible or otherwise by the attending nurse. This program has resulted in a reduction of severe pain levels (NRS≥4) in ICU patients in rest from 41% to 22%. In order to further reduce this percentage, a pain titration protocol is introduced in 2007. As no attention has yet been paid to intervention-related pain levels in these patients, in this prospective study pain control will be studied using different analgesic dosages of morphine iv (2,5 mg vs 7,5 mg) around unavoidable painful interventions within a pain titration protocol for pain control in rest.

Interventions

DRUGmorphine

patients receive 7,5 mg morphine iv 30 minutes before intervention (turning of the patient), the day after admission in the ICU. before, during and after, the patient will be asked to rate the pain using the NRS

Sponsors

Erasmus Medical Center
CollaboratorOTHER
St. Antonius Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients admitted to the ICU of the St. Antonius hospital, between 18-85 years old en weighing between 45-140 kg.

Exclusion criteria

* Pregnancy/ breastfeeding * Language barrier * Known morphine iv allergy * Comatose patients (cooled) * Patients who are suspected to be brain-dead * Unintubated patients on the verge of intubation due to respiratory insufficiency

Design outcomes

Primary

MeasureTime frame
The percentage of patients with a NRS of ≥ 4 during intervention (2.5 mg versus 7.5 mg morphine iv)The first intervention one day after admission

Secondary

MeasureTime frame
The percentage of patients with at least one NRS-score of ≥ 4 at rest during ICU stay10 days
The mean NRS per patient in rest during ICU stay10 days
The percentage of patients with a NRS of ≥ 6 during intervention (2.5 mg versus 7.5 mg morphine iv)one day after admission in the ICU
The mean NRS during an intervention (2.5 mg versus 7.5 mg morphine iv)10 days
Pharmacodynamic parameters of morphine iv (EC50 etc)10 days
Covariates for the PK/PD of morphine iv10 days
Safety and other measures of the analgesics (morphine iv and paracetamol) used for intervention related pain as well as pain titration protocol for pain control in rest.10 days
Pharmacokinetic parameters of morphine iv (volumes of distribution and clearance values)10 days

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026